Claudio Borghi

35.1k total citations · 9 hit papers
623 papers, 17.2k citations indexed

About

Claudio Borghi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Claudio Borghi has authored 623 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 299 papers in Cardiology and Cardiovascular Medicine, 148 papers in Surgery and 115 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Claudio Borghi's work include Blood Pressure and Hypertension Studies (169 papers), Gout, Hyperuricemia, Uric Acid (82 papers) and Lipoproteins and Cardiovascular Health (71 papers). Claudio Borghi is often cited by papers focused on Blood Pressure and Hypertension Studies (169 papers), Gout, Hyperuricemia, Uric Acid (82 papers) and Lipoproteins and Cardiovascular Health (71 papers). Claudio Borghi collaborates with scholars based in Italy, United States and United Kingdom. Claudio Borghi's co-authors include Arrigo F.G. Cicero, Ettore Ambrosioni, Federica Fogacci, Neil R Poulter, Bryan Williams, Aletta E. Schutte, George S. Stergiou, Markus P. Schlaich, Nadia Khan and Agustín J. Ramiréz and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Claudio Borghi

591 papers receiving 16.7k citations

Hit Papers

2020 Internatio... 1995 2026 2005 2015 2020 2020 1995 2018 2015 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2020 International Society of Hypertension Global Hypertension Practice Guidelines
    2020 2.3k citations Claudio Borghi, Neil R Poulter et al. profile →
  2. 2020 International Society of Hypertension global hypertension practice guidelines
    2020 713 citations Claudio Borghi, Neil R Poulter et al. Journal of Hypertension profile →
  3. The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction
    1995 550 citations Ettore Ambrosioni, Claudio Borghi et al. profile →
  4. Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
    2018 451 citations Claudio Borghi et al. profile →
  5. Serum uric acid and the risk of cardiovascular and renal disease
    2015 335 citations Claudio Borghi, Giuseppe Mancia et al. Journal of Hypertension profile →
  6. Dietary linoleic acid and human health: Focus on cardiovascular and cardiometabolic effects
    2019 291 citations Claudio Borghi et al. profile →
  7. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
    2020 249 citations Claudio Borghi, Enrico Agabiti‐Rosei et al. European Journal of Internal Medicine profile →
  8. Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood
    2021 213 citations Claudio Borghi et al. Nutrients profile →
  9. Sex differences in arterial hypertension
    2022 118 citations Claudio Borghi, Gianfranco Parati et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Borghi Italy 56 7.0k 3.3k 3.2k 2.8k 2.1k 623 17.2k
Johan Sundström Sweden 72 6.9k 1.0× 1.6k 0.5× 2.6k 0.8× 3.1k 1.1× 2.3k 1.1× 363 17.0k
Gerjan Navis Netherlands 62 5.1k 0.7× 6.0k 1.8× 2.2k 0.7× 1.9k 0.7× 1.9k 0.9× 444 16.9k
Johan Ärnlöv Sweden 56 4.2k 0.6× 2.7k 0.8× 1.5k 0.5× 2.0k 0.7× 2.0k 0.9× 299 12.6k
Michel Burnier Switzerland 66 7.3k 1.0× 2.7k 0.8× 1.8k 0.6× 3.5k 1.3× 2.4k 1.2× 605 17.1k
Cihat Şarkış Türkiye 6 4.4k 0.6× 4.1k 1.3× 2.6k 0.8× 4.6k 1.7× 2.3k 1.1× 10 18.7k
Hüseyin Kurt Türkiye 5 4.4k 0.6× 4.1k 1.3× 2.6k 0.8× 4.6k 1.7× 2.3k 1.1× 16 18.7k
Yasin Sarı Türkiye 3 4.4k 0.6× 4.1k 1.3× 2.6k 0.8× 4.6k 1.7× 2.3k 1.1× 7 18.7k
Ömer Toprak Türkiye 14 4.5k 0.6× 4.6k 1.4× 2.7k 0.8× 4.6k 1.7× 2.3k 1.1× 31 19.4k
Toshiharu Ninomiya Japan 74 4.8k 0.7× 4.7k 1.4× 2.9k 0.9× 5.6k 2.0× 2.9k 1.4× 383 21.1k
Ali Kırık Türkiye 6 4.4k 0.6× 4.1k 1.3× 2.6k 0.8× 4.6k 1.7× 2.3k 1.1× 14 18.7k

Countries citing papers authored by Claudio Borghi

Since Specialization
Citations

This map shows the geographic impact of Claudio Borghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Borghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Borghi more than expected).

Fields of papers citing papers by Claudio Borghi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Borghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Borghi. The network helps show where Claudio Borghi may publish in the future.

Co-authorship network of co-authors of Claudio Borghi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Borghi. A scholar is included among the top collaborators of Claudio Borghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Borghi. Claudio Borghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giovannini, Marina, Federica Fogacci, Sergio D’Addato, et al.. (2024). Healthy Eating beyond Whole Grains—Insight on Associations between Diet Quality and Arterial Stiffness in the Brisighella Heart Study Cohort. Nutrients. 16(16). 2792–2792.
2.
Masi, Stefano, et al.. (2024). New strategies for the treatment of hyperkalemia. European Journal of Internal Medicine. 132. 18–26. 4 indexed citations
3.
Sukonthasarn, Apichard, et al.. (2024). East meets West: Bringing the ESH 2023 hypertension guidelines into Asia. European Journal of Internal Medicine. 127. 25–30.
4.
Masi, Stefano, et al.. (2024). Gene editing of angiotensin for blood pressure management. International Journal of Cardiology Cardiovascular Risk and Prevention. 23. 200323–200323.
5.
Volpe, Massimo, Claudio Borghi, Matteo Cameli, et al.. (2023). Otto motivi per i quali i cardiologi non dovrebbero trascurare il problema “obesità”. Expert opinion per la pratica clinica. Giornale italiano di cardiologia. 24(9). 677–691. 2 indexed citations
6.
Cicero, Arrigo F.G., Federica Fogacci, Sergio D’Addato, et al.. (2023). Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. Nutrients. 15(2). 312–312. 10 indexed citations
7.
Borghi, Claudio, et al.. (2022). Caffè, ipertensione e malattie cardiovascolari: nuove acquisizioni. Giornale italiano di cardiologia. 23(5). 323–327.
8.
Borghi, Claudio, Alessia Ciancio, Ivan Gentile, et al.. (2022). Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project. Journal of Clinical Medicine. 11(23). 6946–6946. 1 indexed citations
9.
Cicero, Arrigo F.G., Federica Fogacci, Elisabetta Rizzoli, et al.. (2022). Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up. Nutrition Metabolism and Cardiovascular Diseases. 32(9). 2246–2254. 2 indexed citations
10.
11.
Poulter, Neil R, Claudio Borghi, Gianfranco Parati, et al.. (2019). Medication adherence in hypertension. Journal of Hypertension. 38(4). 579–587. 88 indexed citations
12.
Borghi, Claudio & Enrico Strocchi. (2018). Interazioni cuore e apparato digerente. Giornale italiano di cardiologia. 19(4). 203–208. 1 indexed citations
13.
Borghi, Claudio & Arrigo F.G. Cicero. (2016). Nutraceuticals with a clinically detectable blood pressure‐lowering effect: a review of available randomized clinical trials and their meta‐analyses. British Journal of Clinical Pharmacology. 83(1). 163–171. 82 indexed citations
14.
Borghi, Claudio & Claudio Cimminiello. (2016). I nuovi farmaci ipolipemizzanti: focus sugli anticorpi monoclonali. Giornale italiano di cardiologia. 17(4). 14S–21. 1 indexed citations
15.
Cicero, Arrigo F.G., et al.. (2013). Combined Nutraceutical Approach to Postmenopausal Syndrome and Vascular Remodeling Biomarkers. The Journal of Alternative and Complementary Medicine. 19(6). 582–587. 10 indexed citations
16.
Borghi, Claudio, Stefano Bacchelli, & Daniela Degli Esposti. (2012). Long-term clinical experience with zofenopril. Expert Review of Cardiovascular Therapy. 10(8). 973–982. 19 indexed citations
17.
18.
19.
Borghi, Claudio & Stefano Bianchi. (2011). Lo studio Symplicity HTN-2. Giornale italiano di cardiologia. 12(12). 782–6.
20.
Pirodda, Antonio, et al.. (2010). MENIERE’S DISEASE: UPDATE OF ETIOPATHOGENETIC THEORIES AND PROPOSAL OF A POSSIBLE MODEL OF EXPLANATION. Acta Clinica Belgica. 65(3). 170–175. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johan Sundström Breakdown of academic impact, for papers by Gerjan Navis Breakdown of academic impact, for papers by Johan Ärnlöv Breakdown of academic impact, for papers by Michel Burnier Breakdown of academic impact, for papers by Cihat Şarkış Breakdown of academic impact, for papers by Hüseyin Kurt Breakdown of academic impact, for papers by Yasin Sarı Breakdown of academic impact, for papers by Ömer Toprak Breakdown of academic impact, for papers by Toshiharu Ninomiya Breakdown of academic impact, for papers by Ali Kırık
Rankless by CCL
2026